BioSidus

BioSidus is a global company dedicated to providing complex biologics for emerging markets, effectively treating chronic, rare, or life-threatening diseases, thereby improving the lives of millions of patients worldwide. For over 30 years, BioSidus' R&D team has developed nine biosimilars, which are commercially produced at the Almagro API manufacturing site and the Bernal formulation filling facility, both located in Buenos Aires, Argentina. BioSidus has also signed licensing agreements with several large pharmaceutical companies to enrich our portfolio with other third-party biologics. Through an extensive distribution network in emerging markets, we deliver necessary treatment solutions to a broad patient population. BioSidus' regulatory affairs and pharmacovigilance departments oversee the regulatory work for approved products in more than 40 countries and manage ongoing registration processes in another 20 countries. With an outstanding quality record, our products in various formulations and specifications are distributed to over 60 countries worldwide from our logistics center located in Buenos Aires.